JNK1 BUT NOT JNK2 PROMOTES RENAL ISCHAEMIA/REPERFUSION INJURY

K GRYNBERG1,2, E OZOLS1,2, W MULLEY1,2, K BLEASE3, DJ NIKOLICPATERSON1,2, FYMA1,2

1Department of Nephrology, Monash Medical Centre, Clayton, Victoria; 2Centre for Inflammatory Diseases, Monash University, Clayton, Victoria; 3Celgene, San Diego, California, USA

Aim: To determine the relative contribution of JNK1 versus JNK2 in renal ischaemia/reperfusion (I/R) injury.

Background: Tubular activation of the c-Jun amino-terminal kinase (JNK) pathway is prominent in most forms of acute and progressive tubulointerstitial damage, including I/R injury. Both Jnk1 and Jnk2 genes are expressed in most cells of the kidney resulting in considerable redundancy. JNK1 has been linked to apoptosis but its specific role in I/R injury is unknown. Genetic deletion (Jnk1-/- or Jnk2-/-) and selective JNK1 inhibition (CC-90001) were used.

Methods: Bilateral warm renal ischaemia was induced with vascular clamps and animals killed 24hr after reperfusion. Controls were sham operated. Renal I/R injury studies were performed in Jnk1-/- (n=10), Jnk2-/- (n=8) and wild type (WT) mice (n=10). In addition, renal I/R injury was induced in Sprague-Dawley rats with groups (n=8-10) treated 3 times with CC-90001 (10mg/kg) or vehicle starting 1 hour prior to surgery.

Results: Renal I/R injury caused acute renal failure at day 1 in WT mice (178.3±6.5umol/L vs 11.8±3.5umol/L serum creatinine (sCr) in sham con- trol; P<0.001). Jnk2-/- mice had comparable renal failure (sCr 169.8±23.0; P=NS). In a separate study, Jnk1-/- mice showed significant protection from I/R injury compared to WT mice (sCr 40.8±4.7 vs 74.9±11.9umol/L, respectively; P=0.01). This protection was associated with reduced tubular damage and decreased macrophage infiltration. Treatment with CC-90001 provided significant protection in rat I/R injury (sCr 86.4±5.7 vs 193.4±19.2umol/L in drug versus vehicle, respectively; P<0.001). CC-90001 treatment reduced tubular damage and macrophage infiltration.

Conclusions: Using two complementary approaches, we have established that JNK1 is crucial in renal I/R injury. Prophylactic JNK1 inhibition may have clinical utility in anticipate renal I/R injury.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.
/wp-content/uploads/2017/08/Conference-Design-400x400.png
© 2015 - 2016 Conference Design Pty Ltd